James J. K. Liao

Q: What Schools Are Affiliated With James J. K. Liao

James J. K. Liao is affiliated with the following schools: Kyushu University, Hiroshima University, University of Marburg, Ewha Womans University, University of Chicago, University of Medicine and Dentistry of New Jersey, Osaka University, Columbia University, Second Military Medical University, University of Lausanne, National Cheng Kung University, University of California, Riverside, University of Zurich

James J. K. Liao's AcademicInfluence.com Rankings

James J. K. Liao

Chemistry

#1661

World Rank

#2434

Historical Rank

Chemical Engineering

#118

World Rank

#132

Historical Rank

chemistry Degrees

James J. K. Liao

Engineering

#2531

World Rank

#3465

Historical Rank

Bioengineering

#14

World Rank

#16

Historical Rank

Applied Physics

#337

World Rank

#349

Historical Rank

engineering Degrees

Download Badge

Chemistry
Engineering

James J. K. Liao's Degrees

Bachelors Chemical Engineering National Taiwan University

Why Is James J. K. Liao Influential?

(Suggest an Edit or Addition)

(See a Problem?)

James J. K. Liao's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. (1998) (1937)
Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. (1995) (1824)
Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase (2000) (1418)
Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors. (2001) (1282)
Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids. (1999) (1133)
Pleiotropic effects of statins. (2005) (1089)
Post-transcriptional Regulation of Endothelial Nitric Oxide Synthase mRNA Stability by Rho GTPase* (1998) (1062)
Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase. (1998) (1015)
HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. (2008) (906)
Pleiotropic Effects of Statins on the Cardiovascular System (2017) (691)
Induction and Stabilization of IκBα by Nitric Oxide Mediates Inhibition of NF-κB (*) (1995) (687)
Oxidized Low-density Lipoprotein Decreases the Expression of Endothelial Nitric Oxide Synthase (*) (1995) (570)
Genetically elevated C-reactive protein and ischemic vascular disease (2009) (564)
Acute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide synthase (2002) (563)
Pleiotropic effects of statin therapy: molecular mechanisms and clinical results. (2008) (560)
Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy. (2001) (517)
Pleiotropic effects of statins. - Basic research and clinical perspectives -. (2010) (511)
Fatty acid modulation of endothelial activation. (2000) (501)
Isoprenoids as mediators of the biological effects of statins. (2002) (488)
Rho GTPases, statins, and nitric oxide. (2005) (477)
Rho-Kinase Mediates Hypoxia-Induced Downregulation of Endothelial Nitric Oxide Synthase (2002) (457)
Short-Term Statin Therapy Improves Cardiac Function and Symptoms in Patients With Idiopathic Dilated Cardiomyopathy (2003) (435)
3-Hydroxy-3-methylglutaryl-CoA Reductase Inhibitors Attenuate Vascular Smooth Muscle Proliferation by Preventing Rho GTPase-induced Down-regulation of p27 Kip1 * (1999) (418)
Inhibition of 3-Hydroxy-3-methylglutaryl (HMG)-CoA Reductase Blocks Hypoxia-mediated Down-regulation of Endothelial Nitric Oxide Synthase* (1997) (416)
Endothelium-dependent effects of statins. (2003) (392)
Physiological role of ROCKs in the cardiovascular system. (2006) (379)
A mouse model of diet-induced obesity and insulin resistance. (2012) (378)
Rapid nongenomic actions of thyroid hormone (2006) (365)
Rho Kinase (ROCK) Inhibitors (2007) (353)
Inhibition of Rho Kinase (ROCK) Leads to Increased Cerebral Blood Flow and Stroke Protection (2005) (337)
Inhibition of Rho-Kinase Leads to Rapid Activation of Phosphatidylinositol 3-Kinase/Protein Kinase Akt and Cardiovascular Protection (2004) (334)
Mevastatin, an HMG-CoA reductase inhibitor, reduces stroke damage and upregulates endothelial nitric oxide synthase in mice. (2001) (327)
Linking endothelial dysfunction with endothelial cell activation. (2013) (305)
Neuroprotection mediated by changes in the endothelial actin cytoskeleton. (2000) (291)
Suppression of Endothelial Nitric Oxide Production After Withdrawal of Statin Treatment Is Mediated by Negative Feedback Regulation of Rho GTPase Gene Transcription (2000) (290)
Effects of statins on 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition beyond low-density lipoprotein cholesterol. (2005) (285)
Induction and stabilization of I kappa B alpha by nitric oxide mediates inhibition of NF-kappa B. (1995) (275)
Requirement of Rac1 in the development of cardiac hypertrophy. (2006) (274)
Inhibition of Endothelial Vascular Cell Adhesion Molecule-1 Expression by Nitric Oxide Involves the Induction and Nuclear Translocation of IκBα* (1997) (270)
NADPH oxidase-derived superoxide anion mediates angiotensin II-induced cardiac hypertrophy. (2003) (268)
Essential Role of Endothelial Notch1 in Angiogenesis (2005) (268)
Beyond lipid lowering: the role of statins in vascular protection. (2002) (266)
Activation of the Phosphatidylinositol 3-Kinase/Protein Kinase Akt Pathway Mediates Nitric Oxide-Induced Endothelial Cell Migration and Angiogenesis (2003) (264)
Fingolimod provides long‐term protection in rodent models of cerebral ischemia (2011) (263)
NF‐κB and innate immunity in ischemic stroke (2010) (256)
Targeting eNOS for stroke protection (2004) (254)
Risk of Coronary Artery Disease Associated With Polymorphism of the Cytochrome P450 Epoxygenase CYP2J2 (2004) (250)
Differential regulation of endothelial cell adhesion molecule expression by nitric oxide donors and antioxidants (1998) (244)
Activation of Gαs Mediates Induction of Tissue-type Plasminogen Activator Gene Transcription by Epoxyeicosatrienoic Acids* (2001) (242)
Overexpression of cytochrome P450 CYP2J2 protects against hypoxia-reoxygenation injury in cultured bovine aortic endothelial cells. (2001) (240)
Statins and cardiovascular diseases: from cholesterol lowering to pleiotropy. (2009) (237)
Evidence for Statin Pleiotropy in Humans: Differential Effects of Statins and Ezetimibe on Rho-Associated Coiled-Coil Containing Protein Kinase Activity, Endothelial Function, and Inflammation (2009) (228)
RhoA/ROCK signaling is essential for multiple aspects of VEGF‐mediated angiogenesis (2010) (225)
Inflammatory Cytokines and Oxidized Low Density Lipoproteins Increase Endothelial Cell Expression of Membrane Type 1-Matrix Metalloproteinase* (1999) (222)
VEGF increases retinal vascular ICAM-1 expression in vivo. (1999) (214)
Regulation of bovine endothelial constitutive nitric oxide synthase by oxygen. (1995) (213)
Safety and efficacy of statins in Asians. (2007) (211)
Decreased Perivascular Fibrosis but Not Cardiac Hypertrophy in ROCK1+/− Haploinsufficient Mice (2005) (208)
Critical Role of Endothelial Notch1 Signaling in Postnatal Angiogenesis (2007) (207)
Phosphorylation of IRF4 by ROCK2 regulates IL-17 and IL-21 production and the development of autoimmunity in mice. (2010) (202)
Targeting Rho in cardiovascular disease. (2000) (192)
Rapid nontranscriptional activation of endothelial nitric oxide synthase mediates increased cerebral blood flow and stroke protection by corticosteroids. (2002) (191)
Ventricular septal defect and cardiomyopathy in mice lacking the transcription factor CHF1/Hey2 (2002) (191)
Nitric Oxide Inhibits Macrophage-Colony Stimulating Factor Gene Transcription in Vascular Endothelial Cells (*) (1995) (191)
Estrogens and glucocorticoids inhibit endothelial vascular cell adhesion molecule-1 expression by different transcriptional mechanisms. (2000) (187)
Inducible nitric oxide: an autoregulatory feedback inhibitor of vascular inflammation. (1998) (184)
Vascular protective effects of cytochrome p450 epoxygenase-derived eicosanoids. (2005) (182)
Inhibition of Vascular Smooth Muscle Cell Migration by Cytochrome P450 Epoxygenase-Derived Eicosanoids (2002) (181)
Endothelial function and oxidative stress. (2004) (179)
Differential impairment of vasodilator responsiveness of peripheral resistance and conduit vessels in humans with atherosclerosis. (1991) (173)
Direct vascular effects of HMG-CoA reductase inhibitors. (2000) (166)
Rho Kinase Inhibition Improves Endothelial Function in Human Subjects With Coronary Artery Disease (2006) (165)
Statin therapy is associated with improved patency of autogenous infrainguinal bypass grafts. (2004) (162)
Noninvasive method for assessing the human circadian clock using hair follicle cells (2010) (160)
ROCK1 mediates leukocyte recruitment and neointima formation following vascular injury. (2008) (159)
Nitric Oxide Attenuates Vascular Smooth Muscle Cell Activation by Interferon- (1996) (159)
1alpha,25-dihydroxyvitamin D3 induces vascular smooth muscle cell migration via activation of phosphatidylinositol 3-kinase. (2002) (151)
Protective Effects of Statins Involving Both eNOS and tPA in Focal Cerebral Ischemia (2005) (149)
Endothelial Nitric Oxide Synthase-Dependent Cerebral Blood Flow Augmentation by L-Arginine After Chronic Statin Treatment (2000) (148)
Obesity Increases Vascular Senescence and Susceptibility to Ischemic Injury Through Chronic Activation of Akt and mTOR (2009) (148)
The Rho Kinases: Critical Mediators of Multiple Profibrotic Processes and Rational Targets for New Therapies for Pulmonary Fibrosis (2015) (146)
Cloning of CYP2J2 gene and identification of functional polymorphisms. (2002) (143)
Rho-associated coiled-coil-forming kinases (ROCKs): potential targets for the treatment of atherosclerosis and vascular disease. (2011) (143)
Clinical implications for statin pleiotropy (2005) (136)
Rho-kinase inhibition: a novel therapeutic target for the treatment of cardiovascular diseases. (2010) (136)
Inhibition of MHC II gene transcription by nitric oxide and antioxidants. (2004) (132)
Folliculin, the Product of the Birt-Hogg-Dube Tumor Suppressor Gene, Interacts with the Adherens Junction Protein p0071 to Regulate Cell-Cell Adhesion (2012) (132)
Nonnuclear actions of estrogen. (2002) (130)
Increased Vascular Senescence and Impaired Endothelial Progenitor Cell Function Mediated by Mutation of Circadian Gene Per2 (2008) (127)
Statins inhibit Rho kinase activity in patients with atherosclerosis. (2009) (123)
Long-term statin use and psychological well-being. (2003) (123)
Nongenomic Mechanisms of Endothelial Nitric Oxide Synthase Activation by the Selective Estrogen Receptor Modulator Raloxifene (2002) (123)
Translational therapeutics of dipyridamole. (2008) (119)
Rho-Kinase Mediates Hyperglycemia-Induced Plasminogen Activator Inhibitor-1 Expression in Vascular Endothelial Cells (2005) (119)
Atorvastatin Restores Endothelial Function in Normocholesterolemic Smokers Independent of Changes in Low-Density Lipoprotein (2004) (119)
The G proteins of the G alpha i and G alpha q family couple the bradykinin receptor to the release of endothelium-derived relaxing factor. (1993) (117)
Endothelium and acute coronary syndromes. (1998) (115)
Molecular Basis of Cell Membrane Estrogen Receptor Interaction With Phosphatidylinositol 3-Kinase in Endothelial Cells (2003) (114)
Tumor Necrosis Factor-&agr; Downregulates Endothelial Nitric Oxide Synthase mRNA Stability via Translation Elongation Factor 1-&agr; 1 (2008) (114)
Elevated Angiopoietin-2 Level in Patients With Continuous-Flow Left Ventricular Assist Devices Leads to Altered Angiogenesis and Is Associated With Higher Nonsurgical Bleeding (2016) (113)
Inhibition of Vascular Smooth Muscle Cell Proliferation by Sodium Salicylate Mediated by Upregulation of p21Waf1 and p27Kip1 (2000) (113)
Simvastatin Decreases IL-6 and IL-8 Production in Epithelial Cells (2006) (113)
Inhibition of Apoptosis-Regulated Signaling Kinase-1 and Prevention of Congestive Heart Failure by Estrogen (2007) (113)
Rho-Kinase Inhibition Acutely Augments Blood Flow in Focal Cerebral Ischemia via Endothelial Mechanisms (2007) (109)
Structural requirements for inhibition of cytokine-induced endothelial activation by unsaturated fatty acids. (1998) (108)
Rho kinase: an important mediator of atherosclerosis and vascular disease. (2009) (107)
Smooth Muscle Notch1 Mediates Neointimal Formation After Vascular Injury (2009) (106)
Linking Notch signaling to ischemic stroke (2008) (104)
Simvastatin upregulates coronary vascular endothelial nitric oxide production in conscious dogs. (2000) (102)
Isoprenoid metabolism and the pleiotropic effects of statins (2003) (99)
Distribution of sphingosine kinase activity and mRNA in rodent brain (2007) (98)
Novel non-transcriptional mechanisms for estrogen receptor signaling in the cardiovascular system Interaction of estrogen receptor α with phosphatidylinositol 3-OH kinase (2002) (96)
Regulation of Endothelial Nitric Oxide Synthase and Postnatal Angiogenesis by Rac1 (2008) (94)
Roles of rho-associated kinase and oxidative stress in the pathogenesis of aortic stiffness. (2007) (93)
Increased Rho kinase activity in a Taiwanese population with metabolic syndrome. (2007) (92)
Induction of Angiogenesis by Heat Shock Protein 90 Mediated by Protein Kinase Akt and Endothelial Nitric Oxide Synthase (2004) (85)
Preservation of NO production by statins in the treatment of heart failure. (2003) (85)
Modulation of Bradykinin Receptor Ligand Binding Affinity and Its Coupled G-proteins by Nitric Oxide* (1997) (84)
Decreased vascular lesion formation in mice with inducible endothelial-specific expression of protein kinase Akt. (2006) (84)
Acute Reduction of Myocardial Infarct Size By a Hydroxymethyl Glutaryl Coenzyme A Reductase Inhibitor Is Mediated by Endothelial Nitric Oxide Synthase (2003) (83)
Rho Kinases and Cardiac Remodeling. (2016) (81)
Hydrogen peroxide-mediated transcriptional induction of macrophage colony-stimulating factor by TGF-beta1. (1997) (80)
Molecular biology of atherosclerosis. (1997) (80)
A novel pleiotropic effect of statins: prevention of cardiac hypertrophy by cholesterol-independent mechanisms (2003) (80)
FHL2 prevents cardiac hypertrophy in mice with cardiac‐specific deletion of ROCK2 (2013) (79)
Nontranscriptional actions of the glucocorticoid receptor (2003) (76)
RhoA Kinase Inhibition With Fasudil Versus Simvastatin in Murine Models of Cerebral Cavernous Malformations (2017) (74)
Regulation of G-protein alpha i2 subunit expression by oxidized low-density lipoprotein. (1995) (73)
Inhibition of Gi proteins by low density lipoprotein attenuates bradykinin-stimulated release of endothelial-derived nitric oxide. (1994) (73)
Deficiency of ROCK1 in bone marrow‐derived cells protects against atherosclerosis in LDLR−/− mice (2008) (72)
ROCKs as therapeutic targets in cardiovascular diseases (2005) (72)
11,12-epoxyeicosatrienoic acid (11,12-EET): structural determinants for inhibition of TNF-alpha-induced VCAM-1 expression. (2003) (71)
Mineralocorticoid Receptor Blocker Eplerenone Improves Endothelial Function and Inhibits Rho‐Associated Kinase Activity in Patients With Hypertension (2012) (71)
Regulation of Myogenic Terminal Differentiation by the Hairy-related Transcription Factor CHF2* (2001) (71)
Comparison of effects of rosuvastatin (10 mg) versus atorvastatin (40 mg) on rho kinase activity in caucasian men with a previous atherosclerotic event. (2009) (70)
Notch signaling as an important mediator of cardiac repair and regeneration after myocardial infarction. (2010) (70)
Functional interaction of endothelial nitric oxide synthase with a voltage-dependent anion channel (2002) (70)
Notch1 in Bone Marrow–Derived Cells Mediates Cardiac Repair After Myocardial Infarction (2011) (70)
Statins Exert the Pleiotropic Effects Through Small GTP-Binding Protein Dissociation Stimulator Upregulation With a Resultant Rac1 Degradation (2013) (70)
A Functional Role of IκB-ε in Endothelial Cell Activation1 (2000) (69)
Berberine suppresses MEK/ERK-dependent Egr-1 signaling pathway and inhibits vascular smooth muscle cell regrowth after in vitro mechanical injury. (2006) (68)
gamma-Secretase inhibitor reduces diet-induced atherosclerosis in apolipoprotein E-deficient mice. (2009) (66)
Phosphatidylinositol 3-kinase/protein kinase Akt negatively regulates plasminogen activator inhibitor type 1 expression in vascular endothelial cells. (2007) (66)
Rho-Associated Kinase Activity, Endothelial Function, and Cardiovascular Risk Factors (2011) (65)
phosphatidylinositol-3-OH kinase (2000) (65)
Rho/Rho-associated coiled-coil forming kinase pathway as therapeutic targets for statins in atherosclerosis. (2014) (64)
The Rho Kinase Isoforms ROCK1 and ROCK2 Each Contribute to the Development of Experimental Pulmonary Fibrosis (2017) (63)
A method for measuring Rho kinase activity in tissues and cells. (2008) (61)
Novel aspects of the roles of Rac1 GTPase in the cardiovascular system. (2010) (59)
Statin Therapy for Cardiac Hypertrophy and Heart Failure (2004) (58)
Transcription factor CHF1/Hey2 suppresses cardiac hypertrophy through an inhibitory interaction with GATA4. (2006) (57)
Secondary Prevention of Stroke and Transient Ischemic Attack: Is More Platelet Inhibition the Answer? (2007) (56)
The Pleiotropic Effects of Statins - From Coronary Artery Disease and Stroke to Atrial Fibrillation and Ventricular Tachyarrhythmia. (2019) (56)
FHL2/SLIM3 Decreases Cardiomyocyte Survival by Inhibitory Interaction With Sphingosine Kinase-1 (2006) (54)
Specific receptor-guanine nucleotide binding protein interaction mediates the release of endothelium-derived relaxing factor. (1992) (52)
Notch Signaling Regulates Endothelial Progenitor Cell Activity During Recovery From Arterial Injury in Hypercholesterolemic Mice (2010) (51)
Fibroblast deletion of ROCK2 attenuates cardiac hypertrophy, fibrosis, and diastolic dysfunction. (2017) (49)
The release of endothelium-derived relaxing factor via alpha 2-adrenergic receptor activation is specifically mediated by Gi alpha 2. (1993) (48)
Vascular protection by estrogen in ischemia-reperfusion injury requires endothelial nitric oxide synthase. (2003) (47)
Calcium channel blocker and Rho-associated kinase activity in patients with hypertension (2011) (47)
Potential serum biomarkers in the pathophysiological processes of stroke (2014) (47)
Cytochrome P450 epoxygenase CYP2J2 and the risk of coronary artery disease. (2006) (46)
Absence of TRAM Restricts Toll-Like Receptor 4 Signaling in Vascular Endothelial Cells to the MyD88 Pathway (2006) (46)
Increased leukocyte ROCK activity in patients after acute ischemic stroke (2009) (46)
Identification of ROCK1 as an Upstream Activator of the JIP-3 to JNK Signaling Axis in Response to UVB Damage (2008) (45)
Tumor necrosis factor-α levels and non-surgical bleeding in continuous-flow left ventricular assist devices. (2018) (45)
Activated Rho kinase mediates diabetes-induced elevation of vascular arginase activation and contributes to impaired corpora cavernosa relaxation: possible involvement of p38 MAPK activation. (2013) (44)
Atorvastatin Treatment of Cavernous Angiomas with Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) Trial. (2018) (44)
Increased Rho kinase activity in congestive heart failure (2012) (44)
Additive Effects of Statin and Dipyridamole on Cerebral Blood Flow and Stroke Protection (2008) (43)
Rho-Associated Kinase Activity Is a Predictor of Cardiovascular Outcomes (2014) (40)
Rho-Associated Coiled-Coil-Containing Kinase 2 Deficiency in Bone Marrow–Derived Cells Leads to Increased Cholesterol Efflux and Decreased Atherosclerosis (2012) (38)
Monodispersed Fe-Pt nanoparticles for biomedical applications (2005) (37)
ROCK as a therapeutic target for ischemic stroke (2017) (35)
Striatal neurons expressing full-length mutant huntingtin exhibit decreased N-cadherin and altered neuritogenesis. (2011) (35)
Unique fractal evaluation and therapeutic implications of mitochondrial morphology in malignant mesothelioma (2016) (35)
Rac1 Is a Critical Mediator of Endothelium-Derived Neurotrophic Activity (2009) (33)
Non-nuclear actions of estrogen: new targets for prevention and treatment of cardiovascular disease. (2002) (32)
A functional role of I kappa B-epsilon in endothelial cell activation. (2000) (32)
Effect of Aldosterone-Producing Adenoma on Endothelial Function and Rho-Associated Kinase Activity in Patients With Primary Aldosteronism (2015) (32)
Targeting eNOS and beyond: emerging heterogeneity of the role of endothelial Rho proteins in stroke protection (2009) (31)
Rho Kinase Inhibition Blunts Lesion Development and Hemorrhage in Murine Models of Aggressive Pdcd10/Ccm3 Disease (2019) (30)
Pitavastatin-induced angiogenesis and arteriogenesis is mediated by Notch1 in a murine hindlimb ischemia model without induction of VEGF (2011) (29)
Peripheral plasma vitamin D and non-HDL cholesterol reflect the severity of cerebral cavernous malformation disease. (2016) (28)
Increased leukocyte Rho-associated coiled-coil containing protein kinase activity predicts the presence and severity of coronary vasospastic angina. (2012) (28)
Rapid effects of statins: from prophylaxis to therapy for ischemic stroke. (2003) (27)
Emerging views of statin pleiotropy and cholesterol lowering. (2021) (27)
Increased leukocyte rho kinase (ROCK) activity and endothelial dysfunction in cigarette smokers (2010) (25)
Drug Insight: statins and stroke (2005) (24)
The inhibition of endothelial activation by unsaturated fatty acids (2007) (24)
ROCKs as immunomodulators of stroke (2012) (24)
Simvastatin Preserves Cardiac Function in Genetically Determined Cardiomyopathy (2004) (24)
Salicylates and vascular smooth muscle cell proliferation: molecular mechanisms for cell cycle arrest. (2001) (23)
Inhibition of Major Histocompatibility Complex Class II Gene Transcription by Nitric Oxide and Antioxidants* (2002) (23)
ROCK insufficiency attenuates ozone-induced airway hyperresponsiveness in mice. (2015) (23)
Statins and the myocardium. (2004) (23)
Statins and myocardial hypertrophy. (2004) (22)
Statins: potent vascular anti‐inflammatory agents (2004) (22)
Decreased thromboembolic stroke but not atherosclerosis or vascular remodelling in mice with ROCK2-deficient platelets (2017) (22)
Induction of Endothelial-Leukocyte Interaction by Interferon-γ Requires Coactivation of Nuclear Factor-κB (2001) (21)
Measurement of Rho-associated kinase (ROCK) activity in humans: validity of leukocyte p-MBS/t-MBS in comparison with vascular response to fasudil. (2011) (21)
Squalene synthase inhibitor lapaquistat acetate: could anything be better than statins? (2011) (21)
Serine-threonine kinase, ROCK2, regulates germinal center B cell positioning and cholesterol biosynthesis. (2020) (21)
Critical Role of Exogenous Nitric Oxide in ROCK Activity in Vascular Smooth Muscle Cells (2014) (21)
Pleiotropic effects of statin therapy (2009) (21)
Abrogation of airway hyperresponsiveness but not inflammation by rho kinase insufficiency (2015) (20)
Smooth Muscle Notch 1 Mediates Neointimal Formation After Vascular Injury (2009) (19)
Shedding growth factors in cardiac hypertrophy (2002) (19)
Statins and ischemic stroke. (2002) (19)
Targeting Rho-associated coiled-coil forming protein kinase (ROCK) in cardiovascular fibrosis and stiffening (2020) (19)
Inhibition of Rho-kinase attenuates endothelial–leukocyte interaction during ischemia–reperfusion injury (2012) (19)
Is smooth muscle growth in primate arteries regulated by endothelial nitric oxide synthase? (1998) (18)
A combination of increased Rho kinase activity and N-terminal pro-B-type natriuretic peptide predicts worse cardiovascular outcome in patients with acute coronary syndrome. (2013) (18)
Current advances in statin treatment: from molecular mechanisms to clinical practice (2008) (17)
Increase in Blood-Brain Barrier (BBB) Permeability Is Regulated by MMP3 via the ERK Signaling Pathway (2021) (17)
Effect of torcetrapib in patients at high risk for coronary events. (2008) (17)
Elevated homocysteine and C-reactive protein levels independently predict worsening prognosis after stroke in Chinese patients (2010) (16)
Neuroprotection Mediated by Upregulation of Endothelial Nitric Oxide Synthase in Rho-Associated, Coiled-Coil-Containing Kinase 2 Deficient Mice. (2018) (15)
Role of statin pleiotropism in acute coronary syndromes and stroke. (2003) (15)
Simvastatin reverses cardiac hypertrophy caused by disruption of the bradykinin 2 receptor. (2008) (15)
Effect of rosiglitazone on the frequency of diabetes. (2007) (15)
Overexpression of Cytochrome P 450 CYP 2 J 2 Protects against Hypoxia-Reoxygenation Injury in Cultured Bovine Aortic Endothelial Cells (2001) (14)
Long-term follow-up of the West of Scotland Coronary Prevention Study. (2008) (14)
Cross-coupling between the oestrogen receptor and phosphoinositide 3-kinase. (2001) (14)
Cardiology Consultation in the Emergency Department Reduces Re-hospitalizations for Low-Socioeconomic Patients with Acute Decompensated Heart Failure. (2017) (14)
Assessing induction of I?B by nitric oxide (1999) (14)
A Brain-Targeted Orally Available ROCK2 Inhibitor Benefits Mild and Aggressive Cavernous Angioma Disease (2019) (14)
Impaired Cognitive Performance in Endothelial Nitric Oxide Synthase Knockout Mice After Ischemic Stroke: A Pilot Study (2018) (13)
Two functional polymorphisms of ROCK2 enhance arterial stiffening through inhibiting its activity and expression. (2015) (13)
Elevated Rho‐Kinase Activity as a Marker Indicating Atherosclerosis and Inflammation Burden in Polyvascular Disease Patients With Concomitant Coronary and Peripheral Arterial Disease (2013) (13)
[Regulation of endothelial NO production by Rho GTPase]. (1999) (12)
Statin therapy: having the good without the bad. (2004) (12)
Induction of endothelial-leukocyte interaction by interferon-gamma requires coactivation of nuclear factor-kappaB. (2001) (11)
Gene variations of ROCKs and risk of ischaemic stroke: the Women's Genome Health Study. (2014) (11)
Activation of Guanine Nucleotide-binding Proteins and Induction of Endothelial Tissue-type Plasminogen Activator Gene Transcription by Alcohol* (1999) (11)
Association of Rising Violent Crime with Blood Pressure and Cardiovascular Risk: Longitudinal Evidence from Chicago, 2014-2016. (2019) (10)
Regulation der endothelialen NO-Produktion durch Rho-GTPasen (1999) (10)
Rho-kinase: a potential link between hypercholesterolemia and abnormal vascular smooth muscle contraction. (2006) (10)
Rho-Associated Kinase Activity Is an Independent Predictor of Cardiovascular Events in Acute Coronary Syndrome (2015) (9)
Dynamic regulation of endothelial NOS mediated by competitive interaction with α‐actinin‐4 and calmodulin (2008) (9)
Fibroblast deletion of ROCK 2 attenuates cardiac hypertrophy , fibrosis , and diastolic dysfunction (2018) (8)
Role of angiotensin II receptor subtypes in porcine basilar artery: functional, radioligand binding, and cell culture studies. (2006) (8)
MnTBAP stimulates angiogenic functions in endothelial cells through mitofusin-1. (2015) (8)
Lipid management with statins. The lower the better? (2004) (8)
Does it matter whether or not a lipid-lowering agent inhibits Rho kinase? (2007) (7)
Regulator of G‐Protein Signaling 5 Maintains Brain Endothelial Cell Function in Focal Cerebral Ischemia (2020) (7)
Exogenous nitric oxide inhibits Rho-associated kinase activity in patients with angina pectoris: a randomized controlled trial (2015) (7)
MnTBAP increases BMPR-II expression in endothelial cells and attenuates vascular inflammation. (2016) (7)
Rac1 and connective tissue growth factor. The missing link between atrial remodeling and the pathogenesis of atrial fibrillation? (2010) (7)
Fine-tuning the angiogenic response to vascular endothelial growth factor. (2008) (6)
Anti-inflammatory Effects of Simvastatin on Human Oral Cells (2007) (6)
Mitohormesis: another pleiotropic effect of statins? (2012) (6)
Stability via Translation Elongation Factor 1-Downregulates Endothelial Nitric Oxide Synthase mRNA α Tumor Necrosis Factor (2008) (5)
Chapter 8 – The Pleiotropic Effects of Statins: Relevance to Their Salutary Effects (2004) (5)
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein (2009) (5)
This information is current as Feedback Inhibitor of Vascular Inflammation Inducible Nitric Oxide : An Autoregulatory (1998) (5)
ROCK inhibition prevents fetal serum-induced alteration in structure and function of organ-cultured mesenteric artery (2011) (4)
Eplerenone improves endothelial function and arterial stiffness and inhibits Rho-associated kinase activity in patients with idiopathic hyperaldosteronism: a pilot study (2019) (4)
Fatty acid modulation of endothelial activation 1 – 3 (1999) (4)
A practical treatment for COVID‐19 and the next pandemic (2022) (4)
The Effect of Short-Term Simvastatin On Markers of Vascular Dysfunction in Patients with Sickle Cell Disease (SCD). (2009) (4)
Muscle Cell Migration via Activation of Phosphatidylinositol 3-Kinase (2002) (4)
Erratum: Rapid nontranscriptional activation of endothelial nitric oxide synthase mediates increased cerebral blood flow and stroke protection by corticosteroids (Journal of Clinical Investigation (2002) 110 (1729-1738)) (2003) (4)
Assessing induction of I kappa B by nitric oxide. (1999) (4)
HMG-CoA reductase inhibitors reduce cerebral infarct size by upregulating endothelial nitric oxide synthase (1998) (3)
Relative Lack of Culprit and Obstructive Coronary Lesions in Patients With Acute Ischemic Stroke and Elevated Cardiac Troponin. (2016) (3)
Is Mediated by Negative Feedback Regulation of Rho GTPase Gene Transcription Suppression of Endothelial Nitric Oxide Production After Withdrawal of Statin Treatment (2000) (3)
Reduction of Sympathetic Innervation Following Transition to Sacubitril/Valsartan in the Remodel (Reverse Remodeling Effects of Entresto) Study (2018) (3)
Abstract 691: Reduced Human Myocardial mRNA Expression of CYP2J2 in Individuals With the G-50T Promoter Polymorphism (2006) (3)
Nuclear run-on assay to study gene transcription in vascular cells. (1999) (3)
Evidence of pleiotropy by statins: leukocyte Rho kinase (ROCK) activity and pretreated statin before percutaneous coronary interventions are clinical vascular outcome predictors. (2014) (3)
Challenging Statin Pleiotropy: Preeclampsia. (2021) (2)
Abstract 11455: Mechanism Underlying Increased eNOS Expression and Neuroprotection in Mice With Targeted Deletion of ROCK2 (2014) (2)
[New findings on the action of HMG-CoA-reductase inhibitors]. (2008) (2)
Pleiotropic effects of HMG-CoA reductase inhibitors on cells of the vascular wall (2002) (2)
Endothelial Aryl Hydrocarbon Receptor Nuclear Translocator Mediates the Angiogenic Response to Peripheral Ischemia in Mice With Type 2 Diabetes Mellitus (2021) (2)
Vascular Stiffening Mediated by Rho‐Associated Coiled‐Coil Containing Kinase Isoforms (2021) (2)
Toxic action of nitric oxide on myocardial cells: direct evidence from gene transfer in vivo. (1996) (2)
Abstract 5571: Induction of Macrophage Activation and Foam Cell Formation by High Glucose is Mediated by Rho-associated Coiled-coil Forming Kinase (2009) (2)
Involvement of Rho-Associated Coiled-Coil Containing Kinase (ROCK) in BCR-ABL1 Tyrosine Kinase Inhibitor Cardiovascular Toxicity (2022) (2)
Long-term statin use and psychological well-being in the elderly (2003) (2)
Abstract: P730 MODULATION OF NOTCH PROCESSING BY Γ-SECRETASE REDUCED DIET-INDUCED ATHEROSCLEROSIS IN APOLIPOPROTEIN E-DEFICIENT MICE (2009) (1)
Abstract 1426: Decrease Basal Metabolism and Energy Expenditure and Increase Obesity in Mice with Targeted Deletion of ROCK2 (2008) (1)
Increased Angiogenesis and Non-Surgical Bleeding in Patients with Continuous-Flow Left Ventricular Assist Devices Are Mediated by Thrombin-Induced Angiopoietin-2 (2016) (1)
Abstract 13233: Critical Role of Smooth Muscle Rac1 In Neointimal Formation After Vascular Injury (2010) (1)
Community Health Workers Reduce Rehospitalizations and Emergency Department Visits for Low-Socioeconomic Urban Patients With Heart Failure (2019) (1)
Abstract 13172: Critical Role of ROCK2 in Bone Marrow-derived Macrophages in Mediating Atherosclerosis (2010) (1)
Abstract 19339: ROCK2 Mediates the Uptake of Fatty Acids through the Transcriptional Regulation of CD36 (2014) (1)
Fish Intake, Contaminants, and Human Health: Evaluating the Risks and the Benefits Part 1 - Health Benefits (2006) (1)
Clinical trials report (2008) (1)
TNF-alpha Downregulates Endothelial Nitric Oxide Synthase mRNA Stability via Translation Elongation Factor 1-alpha 1 (2009) (1)
Primary prevention of cardiovascular disease with pravastatin. (2007) (1)
Abstract 19727: ROCK2 Mediates Browning of White Fat and Protects Against Obesity (2014) (1)
P099 ROCK Isoforms ROCK 1 and ROCK 2 are Critical for the Development of Pulmonary Fibrosis in Several Different Cell Specific Mechanisms (2016) (1)
Abstract 18253: Reliance on Electrocardiogram Computer Algorithm Interpretation to Activate ST Elevation Myocardial Infarction Processes of Care and Initiate Reperfusion Therapy: Impact on False Activation (2017) (1)
Tie2-Cre–Induced Inactivation of Non-Nuclear Estrogen Receptor-α Signaling Abrogates Estrogen Protection Against Vascular Injury (2022) (1)
(301) - Increased Tumor Necrosis Factor-α Levels in Patients with Continuous-Flow Left Ventricular Assist Devices Mediate Vascular Instability and Are Associated with Higher Non-Surgical Bleeding (2017) (1)
SOCIAL DETERMINANTS OF HEALTH AND CLINICAL HYPERTENSION AND DIABETES PREVALENCE ON CHICAGO'S SOUTH SIDE (2019) (1)
ABL Tyrosine Kinase Inhibitors (TKIs) Are Associated with Increased Rho-Associated Kinase (ROCK) Activity That May Contribute to Vascular Toxicity in Patients with Chronic Myeloid Leukemia (CML) (2018) (1)
Nongenomic Signaling Through the Estrogen Receptor 1953 (2002) (0)
404-3 Dual regulation of endothelial nitric oxide synthase by Rho-kinase (2004) (0)
Abstract 20699: Reduction of Endothelial Arnt Mediates Vascular Dysfunction in Diabetes (2016) (0)
Abstract 3866: The Inhibition of WWP-1 and Activation of AMPKa2 Are Important Mediators of Ischemic Stroke (2012) (0)
ROLE OF STATINS IN ACUTE VASCULAR INFLAMMATION: 345 (2004) (0)
1&agr;,25-Dihydroxyvitamin D3 Induces Vascular Smooth Muscle Cell Migration via Activation of Phosphatidylinositol 3-Kinase (2002) (0)
Decreased Perivascular Fibrosis but Not Cardiac Hypertrophy in ROCK1 (cid:1) / (cid:2) Haploinsufficient Mice (2005) (0)
Critical role of smooth muscle Rac1 in neointimal formation following vascular injury (2017) (0)
Interventional Transcatheter Closure Ameliorates the Leukocyte Rho Kinase Activities among Patients with Patent Ductus Arteriosus. (2015) (0)
Abstract 306: Deficiency of ROCK1 in Macrophages Protects Against Atherosclerosis (2007) (0)
Abstract 17992: Long-Term (10-Year) Mortality of ST Elevation Myocardial Infarction Patients Directly Admitted to Facilities for Primary Percutaneous Coronary Intervention vs Inter-Hospital Transfer: Impact of "Targeted" Use of Pre-Transfer Fibrinolytic Therapy (2017) (0)
Abstract 544: Increase in Isoflurane-mediated Blood-brain-barrier (bbb) Permeability is Regulated by Mmp3 via the Erk Signal Pathway (2020) (0)
Abstract 330: Kinin B1r Inhibitor Prevents Sepsis-induced Cardiac Dysfunction And Promotes Survival In Mice (2022) (0)
Reduction of myocardial infarct size by a HMG CoA-reductase inhibitor in normocholesterolemic rats (2002) (0)
Abstract 525: Adult Inducible Deletion of Endothelial Hypoxia-inducible Factor-2α Exaggerates Myocardial Infarction Induced Heart Failure and Cardiac Microvascular Barrier Dysfunction (2020) (0)
Clinical trials report (2007) (0)
in Endothelial e B- k A Functional Role of I (2000) (0)
A Novel HIF-2α/ARNT Signaling Pathway Protects Against Microvascular Dysfunction and heart failure After Myocardial Infarction (2023) (0)
Abstract 13273: Rising Violent Crime and Changes in Blood Pressure in Chicago (2018) (0)
RhoA/Rho-Associated Kinase as Marker of Cardiovascular Health (2016) (0)
Effect of ramipril on the incidence of diabetes. (2007) (0)
Abstract 63: Reduction in Glucocorticoid Receptor Expression Attenuates Pressure Overload-induced Cardiac Hypertrophy and Promotes Heart Failure in Mice (2016) (0)
Abstract 913: Gamma Secretase Inhibitor Reduces diet-induced Atherosclerosis in Mice by Inhibiting the Notch signaling pathway in inflammatory cells. (2007) (0)
The Pulmonary Endothelium Plays a Critical Role in the Fibrotic Response to Lung Injury Through S1PR1 and ROCK Mediated Cytoskeletal Rearrangements (2019) (0)
inhibitor type 1 expression in vascular endothelial cells Phosphatidylinositol 3-kinase/protein kinase Akt negatively regulates plasminogen activator (2007) (0)
Elevated Rho Kinase (ROCK) Activity Correlates with Acute Rejection in Heart Transplant Recipients (2016) (0)
ANGIOPOIETIN-2 MEDIATES ABNORMAL ANGIOGENESIS AND NON-SURGICAL BLEEDING IN PATIENTS WITH CONTINUOUS-FLOW LEFT VENTRICULAR ASSIST DEVICES (2016) (0)
Rho Kinase (ROCK) Activity is a Predictor of Cardiovascular Outcomes in Patients Undergoing Percutaneous Coronary Interventions (2011) (0)
Role of Endothelial NF-κ B in Vascular Inflammation and Atherosclerosis(Keynote Lecture)(Symposium 4 (SY4) (IHD) : Molecular Mechanism of Atherosclerosis)(Special Program) (2004) (0)
Abstract 3817: Critical Role of Notch1 in Bone Marrow-Derived Stem Cells in Cardiac Regeneration Following Myocardial Infarction (2008) (0)
Abstract 11629: Rho-Associated Kinase (ROCK) Is Activated in Patients with Acute Myocardial Infarction (2011) (0)
Molecular Mechanisms for Statin Pleiotropy and Possible Clinical Relevance in Cardiovascular Disease (2020) (0)
Statins : Are There Benefits Beyond Cholesterol Lowering ? (2002) (0)
CRITICAL ROLE OF FIBROBLAST ROCK2 IN MEDIATING CARDIAC HYPERTROPHY, FIBROSIS, AND DIASTOLIC DYSFUNCTION (2016) (0)
A BUNDLED INTERVENTION INCLUDING EARLY CONSULTATION WITH A CARDIOLOGIST IN THE EMERGENCY DEPARTMENT TO REDUCE RE-HOSPITALIZATIONS AND HEALTHCARE COST FOR HIGH-RISK URBAN PATIENTS WITH ACUTE DECOMPENSATED HEART FAILURE (2017) (0)
Acute neuroprotective effects of cortico steriods mediated by nontranscriptional activation of endothelial nitric oxide synthase (2002) (0)
Abstract 1927: High-dose Simvastatin Alone Inhibits Rho Kinase and Improves Flow-mediated Vasodilatation to a Greater Extent than Combination of Low-dose Simvastatin and Ezetimibe, Despite Comparable Lipid-Lowering (2008) (0)
Abstract 107: Mitochondrial Dysfunction Mediated Myocardial Stunning Following Resuscitation From Cardiac Arrest (2015) (0)
ASSOCIATION OF RISING VIOLENT CRIME WITH CARDIOVASCULAR OUTCOMES: LONGITUDINAL EVIDENCE FROM CHICAGO 2014-2016 (2019) (0)
Evidence for pleiotropic effects of statins in clinical trials (2008) (0)
Nitric oxide regulation of leukocyte adhesion molecule expression (2001) (0)
Non-genomic activation of protein kinase Akt by steroid hormones (2004) (0)
Simvastatin restores contractile function and reduces cardiac remodeling in a genetic model of cardiomyopathy (2003) (0)
Lipid management of cardiovascular disease (2008) (0)
Abstract 829: Endothelial Estrogen Non-nuclear Signaling Plays a Key Role in Anti-remodeling Effects via cGMP Signaling in Failing Heart (2019) (0)
Abstract 12385: Effects of Selective Mineralocorticoid Receptor Blocker Eplerenone on Endothelial Function and the Activity of Rho-Associated Kinase in Patients with Essential Hypertension (2011) (0)
Abstract 4153: High Incidence of Coronary Vasospasm After Sirolimus-Eluting Stent Implantation: Role of Rho-associated Kinase Activation (2009) (0)
Abstract 16357: Standardization of Care Transitions Including Early Cardiology Consultation in the Emergency Department is Associated With Reduced Risk for Readmission in Patients Hospitalized With Acute Decompensated Heart Failure (2016) (0)
Quantitative characterization of atrial fibrillation and flutter waves: A novel approach using spectral signal averaging (1990) (0)
The G Proteins of the Ga1 and Gaq Family Couple the Bradykinin Receptor to the Release of Endothelium-derived Relaxing Factor (2013) (0)
RHO KINASE (ROCK) ACTIVITY CORRELATES WITH CHANGES IN PULMONARY ARTERY PRESSURE AND SEVERITY OF ATRIAL SEPTAL DEFECT (2012) (0)
1 (cid:1) ,25-Dihydroxyvitamin D 3 Induces Vascular Smooth Muscle Cell Migration via Activation of Phosphatidylinositol 3-Kinase (2002) (0)
Triiodothyronine decreased infarct size and improved motor behavior after focal ischemia in SV-129 mice (2003) (0)
Abstract 12774: HMG-CoA Reductase Inhibitors Exert the Pleiotropic Effects through SmgGDS Up-regulation with a Resultant Rac1 Degradation and Reduced Oxidative Stress in vitro and in vivo (2012) (0)
Abstract 15039: ROCK2-Mediated Fibroblast Growth Factor-2 Expression in Cardiac Fibroblasts is Critical for Inducing Cardiac Hypertrophy and Fibrosis (2016) (0)
INCREASED TUMOR NECROSIS FACTOR-A LEVELS IN PATIENTS WITH CONTINUOUS-FLOW LEFT VENTRICULAR ASSIST DEVICES MEDIATE VASCULAR INSTABILITY AND ARE ASSOCIATED WITH HIGHER NON-SURGICAL BLEEDING (2017) (0)
Left Anterior Coronary Artery Ligation / Myocardial Infarction Model (2011) (0)
Statin Pleiotropy: From Mechanistic Insights to Therapeutic Applications (2022) (0)
Abstract 17332: Endothelial-Specific Deletion of Aryl Hydrocarbon Receptor Nuclear Translocator (ARNT) Leads to Microvascular Barrier Dysfunction and Cardiomyopathy (2018) (0)
Acute augmentation of cerebral blood flow by rho-kinase inhibitors in focal cerebral ischemia is dependent on endothelial nitric oxide synthase (2005) (0)
Abstract 150: Early Administration of Ticagrelor in Patients with Non-ST Segment Elevation Myocardial Infarction is Associated with Improved Survival (2019) (0)
Differential Role of ROCK Isoforms on Endothelial Function and Stroke Protection(Keynote Lecture, Vascular Biology in Endothelial Cells (basic), The 71st Annual Scientific Meeting of the Japanese Circulation Society) (2007) (0)
A Brain-Targeted Orally Available ROCK2 Inhibitor Benefits Mild and Aggressive Cavernous Angioma Disease (2019) (0)
Longitudinal Rho-Associated Kinase (ROCK) Activity Correlates with Rejection in Heart Transplant Recipients (2017) (0)
Abstract 306: Endothelial Arnt Mediates Cardiac Remodeling After Ischemia Reperfusion Injury Through an MMP Pathway (2017) (0)
Simvastatin preserves myocardial function by enhancing endothelial nitric oxide production in heart failure (2003) (0)
Abstract 4029: Decreased Rho Kinase (ROCK) Activity by Angiotensin Converting Enzyme Inhibitor (ACEi) is Associated With Improved Left Ventricular Function in Patients With Heart Failure (2009) (0)
Abstract 18963: Over-expression of Angiopoietin-2 in Human Patients With Continuous-flow Left Ventricular Assist Devices Induces Abnormal Angiogenesis and Predicts Gastrointestinal Bleeding Events (2015) (0)
Abstract 14749: Use of Rho-associated coiled-coil forming kinase (ROCK) Activity for Rejection Surveillance in Heart Transplant Recipients (2014) (0)
Blood-brain barrier permeability is regulated by matrix metalloproteinase-3 via the ERK signaling pathway (2020) (0)
Abstract P3140: Targeting Of Kinin B1r/il-6 Signaling Prevents Microvascular Leakage And Mitochondrial Dysfunction In Sepsis Induced Heart Failure (2022) (0)
Abstract P1042: Endothelial Hif-2α Expression Prevents Against Myocardial Infarction Induced Heart Failure And Cardiac Microvascular Barrier Dysfunction (2022) (0)
Is statin discontinuation an option in patients who have had a stroke? (2008) (0)
INCREASED BASELINE RHO KINASE (ROCK) ACTIVITY IS AN INDEPENDENT PREDICTOR OF 6 MONTH CARDIOVASCULAR OUTCOMES AFTER ACUTE CORONARY SYNDROME (ACS) (2010) (0)
Abstract 463: Impairment Of Angiogenesis And Endothelial Progenitor Function By Mutation Of Circadian Gene mPER2 (2007) (0)
Abstract 14746: ROCK2 in Macrophages Inhibits Cholesterol Efflux and Increases Atherosclerosis (2011) (0)
Abstract 101: Endothelial Arnt Regulates Microvascular Endothelial Barrier Function in Heart Failure Through a Novel Mmp3 Pathway (2018) (0)
11,12-EET attenuates infarct in focal cerebral ischemia model and decreases reactive oxygen species-mediated cell death in neuronal cell culture models. (2000) (0)
SALAD‐BAAR: A numerical risk score for hospital admission or emergency department presentation in ambulatory patients with cardiovascular disease (2020) (0)
Abstract 56: Plasma Vitamin D and Non-HDL Cholesterol Reflect the Disease Severity of Cerebral Cavernous Malformation (2016) (0)
VARIATION IN BLOOD PRESSURE AND GLUCOSE AMONG LOW-SOCIOECONOMIC URBAN DWELLERS IS ASSOCIATED WITH DISTANCE FROM HOME TO PHARMACY (2019) (0)
Activation of Phosphatidylinositol 3-Kinase Induces Vascular Smooth Muscle Cell Migration via 3 , 25-Dihydroxyvitamin (2002) (0)
Abstract 5457: Intensive Treatment with Atorvastatin Inhibits Rho Kinase Activity in Patients with Atherosclerosis (2008) (0)
Abstract 16371: High Levels of Tumor Necrosis Factor-α in Patients With Continuous-Flow Left Ventricular Assist Devices Mediate Altered Vessel Growth and Are Associated With Higher Non-Surgical Bleeding (2016) (0)
Endothelial-specific Ablation of Non-nuclear Estrogen Receptor alpha Signaling Deteriorates Vascular Remodelling Response (2020) (0)
Abstract WMP120: Critical Role of RGS5 in Modulating Blood-Brain Barrier Integrity During Focal Cerebral Ischemia (2018) (0)
CHARACTERISTICS ASSOCIATED WITH FUTURE ADMISSION IN AMBULATORY HEART FAILURE PATIENTS (2019) (0)
Cellular Interactions and Immunological Mechanisms (2005) (0)
Endothelial Biomedicine: Statins (2007) (0)
819-5 Atorvastatin restores endothelial function in normocholesterolemic smokers (2004) (0)
S15-03 Risk of hypertension and cardiovascular disease in patients with polymorphism in cytochrome p450 2J2 (2004) (0)
Endothelial Biomedicine: Steroid Hormones (2007) (0)
Endothelial vasomotor function in humans: relation to the expression of endothelial nitric oxide synthase (2002) (0)
Abstract 13004: Intensive Lipid-Lowering Therapy by Pitavastatin Ameliorates Coronary Hypercontraction After Stenting, the CONTRACTION Study (2011) (0)
Atherosclerotic risk factors Hypertension Cigarette smoking Hypercholesterolemia Diabetes mellitus Male gender Increased age Family history of atherosclerosis (1998) (0)
S11-01 Initiation and development of acute coronary syndrome (2004) (0)
Anti-inflammatory properties of NO (2001) (0)
anti-inflammatory actions of eicosanoids derived from cytochrome p450 opoxigenasa. (2000) (0)
Abstract 489: ROCK2, but not ROCK1, Mediates NO-dependent Neuroprotective Effects Following Transient Focal Cerebral Ischemia (2006) (0)
Obesity-Induced Airway Hyperresponsiveness In Mice: Role Of Rho Kinase (2011) (0)
Abstract 258: Impact of Community Health Workers in Management of Heart Failure: A Pilot Study (2018) (0)
5 Notch Signaling Mediates Endothelial Progenitor Cell Fate in Injury-induced Arterial Remodeling under High Cholesterol Condition(A New Era in Atherosclerosis Research, The 71st Annual Scientific Meeting of the Japanese Circulation Society) (2007) (0)
Cardiomyocyte‐Specific Racl Deletion Prevents Angiotensin Il‐Induced Oxidative Stress and Cardiac Hypertrophy (2005) (0)
eNOS Upregulation and Infarct Reduction by Mevastatin, an HMG-CoA Reductase Inhibitor (1999) (0)
Abstract 794: Endothelial Specific Ablation of Estrogen Receptor Alpha Rapid Signaling Revealed Exacerbated Vascular Remodeling Response (2019) (0)
Review article B lipid lowering: the role of statins in vascular protection (2002) (0)
Abstract 12171: Rho Kinase (ROCK) Activity is a Predictor of Cardiovascular Outcomes in Patients Undergoing Percutaneous Coronary Interventions (2011) (0)
Abstract 462: Worsening of Endothelial Function in Mice with Endothelial-specific Haploinsufficiency of Rac1 (2006) (0)
Abstract 17199: Platelet ROCK2 is an Important Mediator of Thrombotic Stroke (2011) (0)
Understanding the molecular mechanisms of statin pleiotropic effects (2023) (0)
Induction of Endothelial-Leukocyte Interaction by Interferon-&ggr; Requires Coactivation of Nuclear Factor-&kgr;B (2001) (0)
Abstract 20625: False Activation of the Emergency Department for Triaged Patients With Presumed STEMI is Associated With Worse Long Mortality (2017) (0)
Abstract 552: Bradykinin Receptor B1/ Matrix Metalloprotease 3 Pathway is a Novel Target in Preventing Cardiac Ischemia-reperfusion Injury (2020) (0)
Abstract 1012: Notch Signaling Mediates Endothelial Progenitor Cell Fate in Injury-induced Arterial Remodeling under High Cholesterol Condition (2006) (0)
Tumor Necrosis Factor- (cid:1) Downregulates Endothelial Nitric Oxide Synthase mRNA Stability via Translation Elongation Factor 1- (cid:1) 1 (2008) (0)
Abstract MP250: Reduction In Endothelial Aryl Hydrocarbon Receptor Nuclear Translocator (arnt) Mediates Vascular Dysfunction In Mice With Type 2 Diabetes Mellitus (2021) (0)
ROCK2 Deficiency in Bone Marrow-Derived Cells Leads to Increased Cholesterol Efflux and Decreased Atherosclerosis (2012) (0)
Deficiency of Rho Kinase 1 (ROCK1) attenuates neutrophil NETosis and ameliorates UVB-induced skin inflammation (2021) (0)
SALAD-BAAR: A NUMERICAL RISK SCORE FOR ADMISSION OR ER PRESENTATION IN AMBULATORY CARDIOLOGY PATIENTS (2020) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With James J. K. Liao?

James J. K. Liao is affiliated with the following schools:

James J. K. Liao's Academic­Influence.com Rankings

James J. K. Liao's Degrees

Why Is James J. K. Liao Influential?

James J. K. Liao's Published Works

Published Works

What Schools Are Affiliated With James J. K. Liao?

James J. K. Liao's AcademicInfluence.com Rankings